GLP-1 Shortages Raise Questions About Prioritizing Access For Diabetics

Ozempic News

GLP-1 Shortages Raise Questions About Prioritizing Access For Diabetics
ShortagesGLP-1SType 2 Diabetes
  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 47 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 53%
  • Publisher: 59%

I'm an independent healthcare analyst with more than 25 years of experience analyzing, publishing and presenting/educating on healthcare policy and pharmaceuticals. I have 114 publications in peer-reviewed journals, in addition to more than 450 articles in periodicals and newspapers. I have also presented my work at numerous conferences.

2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. But now they're in short supply for diabetic patients. Photographer: George Frey/BloombergAs consumer demand has skyrocketed for GLP-1 medications to reduce weight this has created substantial supply issues. Sometimes type 2 diabetic patients can’t obtain medically necessary GLP-1 drugs.

With so many individuals now being prescribed GLP-1s for weight loss, shortages of the drugs have become chronic. To illustrate, some type 2 diabetics have been unable to get the GLP-1s Ozempic andby Anthem Blue Cross Blue Shield suggests that the percentage could be much higher. Of the patients for whom doctors prescribed Ozempic, Anthem’s review found that more than 60% lacked “sufficient evidence” of diabetes.

While drug manufacturers have invested in factories and are ramping up production of GLP-1s, it’s unclear how soon the shortages will be resolved. Athis a “major public health concern.” It has advised medical professionals to only prescribe these medicines for their licensed uses and that it is necessary to strictly adhere to national clinical practice guidelines.have explicitly asked clinicians not to prescribe GLP-1s for obesity and instead reserve them for people with type 2 diabetes.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ForbesTech /  🏆 318. in US

Shortages GLP-1S Type 2 Diabetes Weight Loss Obesity Mounjaro Zepbound Wegovy Access

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Europe Acts to Address GLP-1 Drug ShortagesEurope Acts to Address GLP-1 Drug ShortagesEurope's drug authorities warn that off-label use is exacerbating shortages and placing the public at risk for serious harm.
Read more »

Thyroid Warning on GLP-1s Could Raise Overdiagnosis RiskThyroid Warning on GLP-1s Could Raise Overdiagnosis RiskAn endocrinologist argued that a prudent approach is needed to screen for thyroid nodules in people taking the widely used weight loss drugs.
Read more »

Deadpool & Wolverine's Official Pizzas Raise Some Meaty QuestionsDeadpool & Wolverine's Official Pizzas Raise Some Meaty QuestionsMarvel teamed up with DiGiorno on four limited edition offerings tied to the July 26 release.
Read more »

Elwood Technologies’ Large ETH Transfers Raise Questions Amid Acquisition TalksElwood Technologies’ Large ETH Transfers Raise Questions Amid Acquisition TalksCrypto Blog
Read more »

Elias: California wildfire smoke’s fatal effects raise liability questionsElias: California wildfire smoke’s fatal effects raise liability questionsNate is an East Bay community papers editor for the Bay Area News Group and East Bay Times. He edits the Hills weekly Alameda Journal, Berkeley Voice, El Cerrito Journal, Montclarion and Piedmonter newspapers; Central Costa County's weekly Concord Transcript and Walnut Creek Journal papers; and East Contra Costa's weekly East County News.
Read more »

21 Questions Game: Dig Deep with 165 Fun & Flirty Questions21 Questions Game: Dig Deep with 165 Fun & Flirty QuestionsPlay the 21 questions game and you'll get to know anyone better! Find 21 questions (and then some) to ask to spark deep conversations with a friend or crush.
Read more »



Render Time: 2025-02-15 10:22:24